Abstract-The D2 receptor and two distinct affinity 5-HT2 receptors in the human prefrontal cortex were labeled with 3H-spiperone.
Binding assay techniques allow for a direct labeling of neurotransmitter receptors with radiolabeled agonists and antagonists in both the human and animal brain and provide a feasible approach for investigations on biochemical characteristics of neuro transmitter receptors. Using recently developed selective antagonists and agonists, subtypes of receptors such as D,, D2, D3 and D4 for the dopamine receptor (1) have been differentiated as well as 5-HT, and 5-HT2 for the serotonin receptor (2) (3) (4) . Elevation in the binding site of 3H-butyrophenones has been detected in the striatum and nucleus accumbens from schizophrenic patients (1, 5, 6) . However, these brain areas do not immediately seem related to some of the classical symptoms seen in schizophrenic patients. These symptoms such as the abnormality in thought, a spontaneity and emotional disturbances are more likely to be related to disorders of the prefrontal cortex than to those of the basal ganglia (7, 8) . Although changes in the binding levels of 3H-LSD to the frontal cortex in schizophrenics (9, 10) and the identification of D, receptor subunits in the human frontal cortex (11) have been reported, the D2 receptor which is a possible site for neuroleptic actions (12) and the 5-HT2 receptor have not been identified in the human prefrontal cortex. Recently, a procedure was developed to identify D2 and 5-HT2 receptors separately and selectively using 3H-spiperone, and the density of each receptor in different regions of the rat brain (13) could be feasibly measured. These results prompted us to further investigate the D2 and 5-HT2 re ceptors in the human prefrontal cortex. We have now identified and characterized the D2 and 5-HT2 receptors in the prefrontal cortex of the autopsied human brain using specific antagonists for D2 and 5-HT2 receptors, respectively.
MATERIALS AND METHODS
Human brains were obtained at autopsy from individuals who had died of causes unrelated to psychiatric or neurological diseases. All the subjects were male and the average age at death was 56 years. The interval between death and freezing of the brains at -75°C was 2 to 12 hr.
Crude membrane preparations from the prefrontal cortex (Areas 9, 10, 11 and 12, according to Brodmann) were prepared as follows: tissues were weighed, homogenized in 5 ml of ice cold 50 mM Tris/HCI buffer, pH 7.4, with a polytron (Brinkman PT-10; setting of 7, 20 sec) and centrifuged at 48,000 g for 10 min. The pellets were washed twice or five times by centrifugation and resuspension in the same Tris buffer and were then stored at -75'C until the time of binding assay.
Before use, homogenates were thawed and homogenized using the same method. Crude membrane preparations (0.47 to 0.65 mg protein/tube) were incubated with 3H spiperone (21 Ci/mmol; RCC Amersham) in 2 ml of 50 mM Tris/HCI buffer, pH 7.4, containing 0.01% ascorbic acid for 10 min at 37°C, in triplicate. After incubation, these membranes were rapidly passed through Whatman GF/B glass fiber filters and rinsed three times with 8 ml of ice cold 50 mM Tris/HCI buffer. Radioactivity on the dried filter was counted using Triton-toluene scin tillant and a liquid scintillation spectrometer at efficiencies of 40-45%. Protein contents were determined by the method of Lowry et al. to the 5 times washed membrane preparations, was saturable and exhibited a biphasic pattern. As shown in Fig. 1 , the Scatchard analysis showed the existence of two high affinity binding sites in the prefrontal cortex. These binding sites had apparent KD values of 0.028 nM and 0.64 nM and apparent density values of 25 fmol/mg protein and 132 fmol/mg protein for the higher and lower affinity sites, re spectively. In the twice washed membrane preparations, the saturation isotherms of stereoselective 3H-spiperone binding were monophasic indicating only the lower affinity sites with an apparent KD of 0.69 nM and an apparent density of 87 fmol/mg protein (Fig. 1) .
Characterization of 3H-spiperone binding sites by drug displacement experiments: Under these specified conditions we could consistently demonstrate two high affinity stereoselective 3H-spiperone binding sites in the human prefrontal cortex; therefore, the drug displacement experiments using sulpiride, haloperidol, (+)-butaclamol, and ketanserin were carried out with 0.05 nM and 0.5 nM 3H-spiperone in order to charac terize the higher and lower affinity sites, respectively ( Fig. 2A, B) . Sulpiride, an antagonist which is 1,800 times more potent on D2 than on 5-HT2 receptors (15) , was used to displace 3H-spiperone from D2 receptors.
The displacement curve of 3H-spiperone binding at 0.05 nM by sulpiride was clearly biphasic and displayed an intermediary plateau. The apparent IC50 value for sul piride sensitive sites inhibited by sulpiride at low concentration in the prefrontal cortex ( Fig. 2A ) was about 10 ,eM and was much the same as that in the caudate nucleus (data not shown). Haloperidol which is 33 times more potent on D2 receptors than on 5-HT2 receptors (15, 16) gave a similar biphasic displacement curve ( Fig. 2A) . On the con trary, (+)-butaclamol which is only 3.8 times more potent on D2 receptors than on 5-HT2 receptors (16) displayed a monophasic inhibition of 3H-spiperone binding in the prefrontal cortex ( Fig. 2A) , with a much lesser potency than in the caudate nucleus (data not shown). Ketanserin, a recently developed antagonist for the 5-HT2 receptor, which has a 100 times more potent affinity to 5-HT2 receptors than to D2 receptors (17) gave a biphasic displacement curve. As shown in Fig. 2A , ketanserin was most potent in inhibiting the binding of 0.05 nM 3H spiperone to the human prefrontal cortex. Ketanserin inhibited about 80% of the specific binding stereoselective binding at 10 nM in the prefrontal cortex ( Fig. 2A) , whereas only 20% of the specific binding was inhibited at this concentration in the caudate nucleus (data not shown). In addition, drug displacement experiments using 0.5 nM 3H spiperone were performed in an attempt to characterize the lower affinity sites (Fig. 2B) . In this case, the sulpiride displacement curve was monophasic, and inhibition was not seen at concentrations lower than 10 flM. Ketanserin inhibited 3H-spiperone binding most potently; and at 0.1 i M, a complete inhibition of the specific 3H-spiperone binding occurred.
Specific 3H-spiperone binding to 5-HT2 receptors in the human prefrontal cortex: The specific 3H-spiperone binding to 5-HT2 receptors was defined as the amount of bound 3H-spiperone which is inhibited by the presence of 0.1 ,uM ketanserin in the presence of 10 aM sulpiride (to preclude the attach ment of the 3H-spiperone to D2 receptors). The 3H-spiperone (0.02-2 nM) binding to 5-HT2 receptors in the prefrontal cortex showed biphasic saturation isotherms. Scatchard analysis clearly revealed the ex istence of two high affinity components of 5-HT2 receptors (Fig. 3) . The apparent KD values of the higher and lower affinity com ponents were 0.091 and 1.27 nM, respec tively. The apparent density values for the higher affinity sites and total density were 15 fmol/mg protein and 124 fmol/mg protein, respectively.
DISCUSSION
In the present experiment, we demon strated the existence of two high affinity stereoselective 3H-spiperone binding sites in the human prefrontal cortex. Extensively washed membrane preparations proved to be the primary requisite for observation of biphasic saturation isotherms, and these observations are consistent with the biphasic isotherms obtained in the case of the rat striatum (18) . All these findings suggest the presence of endogenous inhibitors of 3H spiperone binding other than dopamine or serotonin because these amines are very weak displacers of 3H-spiperone from D2 or 5-HT2 receptors (1, 4, 18) . As butaclamol displaces stereoselectively the binding of 3H-LSD from central serotonin receptors (19) as well as the binding of 3H-spiperone from dopamine receptors, the two high affinity stereoselective 3H-spiperone binding sites in the prefrontal cortex appear to include these two components. It is thus essential to differentiate these two components of 3H spiperone binding in the prefrontal cortex which receives both dopaminergic and sero tonergic innervation (8, (20) (21) (22) (23) (24) .
Furthermore, we attempted to differentiate subtypes of dopamine and serotonin receptors in the human frontal cortex using selective antagonists: sulpiride for the D2 receptor and ketanserin (17) for the 5-HT2 receptor. The drug displacement experiments by various antagonists using 0.05 and 0.5 nM 3H spiperone characterized the higher and lower affinity 3H-spiperone binding sites as shown in Fig. 2 . The displacement curves of 0.05 nM 3H-spiperone by various antagonists indicated that 3H-spiperone binding sites displaced by low concentrations of sulpiride or haloperidol are the dopaminergic D2 component and occupy 20-30% of the total higher affinity sites. From the appearance of the drug displacement curve with sulpiride, the D2 component in the human prefrontal cortex may have similar characteristics to those in the human (data not shown) and rat caudate nucleus (13) .
Conversely, the 5-HT2 component dis placed by a low concentration of ketanserin seems to be a major component of the higher affinity sites. Our drug displacement experi ments using 0.5 nM 3H-spiperone revealed that most of the lower affinity binding sites have the characteristics of the 5-HT2 receptor. From the results obtained by the displacement experiments using different concentrations of 3H-spiperone, it was suggested that in the prefrontal cortex, there were two distinct components of 5-HT2 receptors which have higher and lower affinities for 3H-spiperone. A further saturation experiment also demon strated the existence of two high affinity 5 HT2 receptors in the prefrontal cortex. The apparent density values for specific 3H spiperone binding to 5-HT2 receptors were slightly smaller than those for the stereoselec tive 3H-spiperone binding sites. This com parison of the density values obtained by two saturation experiments indicated that most of the stereoselective 3H-spiperone binding sites are 5-HT2 receptors and that the contribution of the D2 component is not so great.
The present study provides the first evidence for the existence of D2 dopamine and two 5-HT2 receptors with different affinities in the human prefrontal cortex. As it is highly probable that the antipsychotic effects of neuroleptics are attributable to their ability to block D2 receptors (12) , the D2 receptor in the prefrontal cortex may be a possible site for the therapeutic action of neuroleptics in schizophrenics. Abnormalities in two distinct 5-HT2 receptors identified along with the D2 receptor may be associated with psychotic disorders.
